• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

System of adverse drug reactions reporting: What, where, how, and whom to report?

作者信息

Kalaiselvan Vivekanandan, Kumar Pranay, Mishra Prabhakar, Singh Gyanendra Nath

机构信息

National Coordination Centre-Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, Uttar Pradesh, India.

出版信息

Indian J Crit Care Med. 2015 Sep;19(9):564-6. doi: 10.4103/0972-5229.164819.

DOI:10.4103/0972-5229.164819
PMID:26430348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4578206/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/4578206/941ac1957305/IJCCM-19-564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/4578206/cdc12e145fde/IJCCM-19-564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/4578206/941ac1957305/IJCCM-19-564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/4578206/cdc12e145fde/IJCCM-19-564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/4578206/941ac1957305/IJCCM-19-564-g002.jpg

相似文献

1
System of adverse drug reactions reporting: What, where, how, and whom to report?药品不良反应报告系统：报告什么、在哪里报告、如何报告以及向谁报告？
Indian J Crit Care Med. 2015 Sep;19(9):564-6. doi: 10.4103/0972-5229.164819.
2
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting.住院期间药物不良反应的发生率及成本：计算机化监测与激发自发报告法的比较
Drug Saf. 2000 Feb;22(2):161-8. doi: 10.2165/00002018-200022020-00007.
3
Testing an explanatory model of nurses' intention to report adverse drug reactions in hospital settings.检验医院环境中护士报告药品不良反应意愿的解释模型。
J Nurs Manag. 2017 May;25(4):307-317. doi: 10.1111/jonm.12467. Epub 2017 Jan 27.
4
Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.非洲医疗消费者直接报告药物不良反应：叙事性综述。
Int J Clin Pharm. 2021 Feb;43(1):11-24. doi: 10.1007/s11096-020-01141-x. Epub 2020 Sep 9.
5
Awareness of Adverse Drug Reactions and its Reporting among Third-year Undergraduate Medical Students.本科三年级医学生对药物不良反应的认知及其报告情况
J Nepal Health Res Counc. 2022 Mar 13;19(4):762-766. doi: 10.33314/jnhrc.v19i04.3714.
6
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System.药物的聚乙二醇化是否与过敏反应有关？对意大利国家自发药物不良反应报告系统的分析。
Drug Saf. 2023 Apr;46(4):343-355. doi: 10.1007/s40264-023-01277-5. Epub 2023 Feb 15.
7
Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.医务人员在巴格达市报告药物不良反应的经验：横断面研究。
Int J Clin Pharm. 2019 Oct;41(5):1307-1313. doi: 10.1007/s11096-019-00867-7. Epub 2019 Jun 25.
8
Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.尼日利亚门诊患者对不良反应的知识、意识、看法和报告。
Int J Clin Pharm. 2019 Aug;41(4):1062-1073. doi: 10.1007/s11096-019-00849-9. Epub 2019 May 28.
9
Monitoring drug safety in Astrakhan, Russia.俄罗斯阿斯特拉罕地区的药物安全监测。
Int J Risk Saf Med. 2015;27 Suppl 1:S33-4. doi: 10.3233/JRS-150680.
10
Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports.护士对药物不良反应的自发报告：常规报告的专家评审
J Nurs Manag. 2014 Apr;22(3):322-30. doi: 10.1111/jonm.12003. Epub 2012 Nov 2.

引用本文的文献

1
Strengthening Dental Materiovigilance: A Review of International Reporting Frameworks.加强牙科药物警戒：国际报告框架综述
Int Dent J. 2025 Aug 6;75(5):100943. doi: 10.1016/j.identj.2025.100943.
2
Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions.美国食品药品监督管理局不良事件报告系统（FAERS）报告的婴儿使用质子泵抑制剂的真实世界安全性概况：小婴儿，关键决策。
Pharmaceuticals (Basel). 2025 May 16;18(5):730. doi: 10.3390/ph18050730.
3
Drug Safety During Breastfeeding: A Comparative Analysis of FDA Adverse Event Reports and LactMed.

本文引用的文献

1
Helpline facility to assist reporting of adverse drug reactions in India.印度提供帮助报告药品不良反应的热线服务。
WHO South East Asia J Public Health. 2014 Apr-Jun;3(2):194. doi: 10.4103/2224-3151.206737.
2
Status of documentation grading and completeness score for Indian individual case safety reports.印度个体病例安全报告的文件分级和完整性评分状况
Indian J Pharmacol. 2015 May-Jun;47(3):325-7. doi: 10.4103/0253-7613.157133.
3
Adverse drug reactions reporting culture in Pharmacovigilance Programme of India.印度药物警戒计划中的药品不良反应报告文化
母乳喂养期间的药物安全性：FDA不良事件报告与LactMed的比较分析
Pharmaceuticals (Basel). 2024 Dec 9;17(12):1654. doi: 10.3390/ph17121654.
4
Impact of Sensitization on School Teachers' Knowledge and Attitudes Towards Adverse Drug Reaction Reporting During National Deworming Day: A Prospective Quasi-Experimental Study.致敏对学校教师在全国驱虫日期间关于药品不良反应报告的知识和态度的影响：一项前瞻性准实验研究。
Cureus. 2024 Nov 7;16(11):e73209. doi: 10.7759/cureus.73209. eCollection 2024 Nov.
5
A Cross-Sectional Evaluation of Knowledge of Medicine Safety and Frequency of Reading Medication Leaflets and Its Predictors - Insights from Saudi Adults in Riyadh, Saudi Arabia.一项关于药物安全知识、阅读药品说明书频率及其预测因素的横断面评估——来自沙特阿拉伯利雅得成年居民的见解
Int J Gen Med. 2024 Jan 19;17:175-186. doi: 10.2147/IJGM.S446041. eCollection 2024.
6
A Qualitative Study of Stakeholders' Views on Pharmacovigilance System, Policy, and Coordination in Pakistan.关于巴基斯坦利益相关者对药物警戒系统、政策及协调的观点的定性研究
Front Pharmacol. 2022 Jun 9;13:891954. doi: 10.3389/fphar.2022.891954. eCollection 2022.
7
Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India.印度通过《印度药物警戒计划》的结果报告药物不良事件报告工具和监管措施。
Indian J Pharmacol. 2021 Mar-Apr;53(2):143-152. doi: 10.4103/ijp.ijp_901_20.
8
An observational study to assess the possibility of patient participation in implementing pharmacovigilance in a busy tertiary care hospital.一项观察性研究，旨在评估在一家繁忙的三级医疗医院中患者参与实施药物警戒的可能性。
Med J Armed Forces India. 2020 Oct;76(4):425-429. doi: 10.1016/j.mjafi.2019.08.004. Epub 2019 Dec 16.
9
Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.基于家庭的抗结核治疗不良反应（HATTAR）研究：一项前瞻性观察研究方案。
BMJ Open. 2019 Mar 30;9(3):e027321. doi: 10.1136/bmjopen-2018-027321.
10
Another feather in the crown of medical safety and ethics in India.印度医疗安全与伦理领域的又一项成就。
Perspect Clin Res. 2017 Jul-Sep;8(3):152. doi: 10.4103/2229-3485.210448.
Indian J Med Res. 2014 Oct;140(4):563-4.
4
International drug monitoring: the role of national centres. Report of a WHO meeting.国际药品监测：国家中心的作用。世界卫生组织会议报告。
World Health Organ Tech Rep Ser. 1972;498:1-25.